Cargando…
Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination
Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous rep...
Autores principales: | Zhang, Huailin, Sanchez Gomez, Diana, Repajic, Michael, Liu, Antonio K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334026/ https://www.ncbi.nlm.nih.gov/pubmed/35910698 http://dx.doi.org/10.7759/cureus.27422 |
Ejemplares similares
-
Pfizer-BioNTech COVID-19 vaccine label update on Bell's palsy in Canada
Publicado: (2021) -
Covid-19-vaccine-Pfizer-BioNTech/prednisone: Hypertension, injection-site soreness and recurrence of Bell's palsy: case report
Publicado: (2021) -
Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy
por: Repajic, Michael, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)